Replies to post #27786 on CBA Florida Inc. (fka CBAI)

[MrLong]

Could there be a study underway right now that was cancelled then (June 2009) but then rescheduled (Nov 2009) and continues to be underway today (March 2010)? Anything is possible.

This company has deeper connections in the new-aged stem cell world and it is maturing rapidly. I believe the revenues will reflect it. If not now then soon!

From that list I posted of the 150 companies that are entering a new $6.9B cures marketplace the standouts for this discussion are:

CorCell Inc,
Pluristem Therapeutics Inc.,
Osiris Therapeutics Inc


1) PLURISTEM THERAPEUTICS INC. (NASDAQCM: PSTI)
Proprietary Technologies Place
Pluristem in the Vanguard of a Cellular
Therapeutics Revolution - July 2009
http://www.pluristem.com/Griffin_PSTI_Initiation_Report_07July09.pdf
This was on then off... might account for the CEO's statement not materializing. Osiis Therapeutics listed on page #2

2) PLURISTEM THERAPEUTICS (NASDAQCM:PSTI)
• Early Phase I data encouraging; treatment of first patient cohorts in Germany and the United States commence on schedule - November 2009
http://www.pluristem.com/Griffin%20PSTI%20update%20report%2017Nov%202009%20(2).pdf
Testing Back on Again.

3) Osiris Therapeutics is a part of this study. Search the literature